Abstract Background: According to the new definition of septic shock, vasopressor therapy and hyperlactatemia are essential for diagnosis. However, there is controversy regarding the cutoff value for lactate, and prognostic factors in patients with septic shock and hypolactatemia. This study evaluated the prognostic significance of the cutoff value for lactate level in septic shock patients. Methods: The retrospective observational cohort study enrolled 1043 patients aged !18 years who meet the revised definition of septic shock. Clinical outcomes of patients with hyperlactatemia were compared with hypolactatemia. Results: Of the 1022 eligible patients, 369 had an arterial lactate level 2 mmol/L. More patients in the high lactate group had poor prognosis than in the low lactate group. A high Sequential Organ Failure Assessment score (SOFA) score group was significant (p < 0.001) in predicting lactate levels. On the subgroup analysis of risk factors affecting mortality in the low lactate group, high Acute Physiology And Chronic Health Evaluation Ⅱ (APACHEⅡ) score (p Z 0.003), high C-reactive protein (p Z 0.034), and chronic heart failure (p Z 0.001) were independently associated with 28-day mortality. Conclusion: Arterial lactate is a very reliable diagnostic and prognostic predictor of septic shock. However, despite low arterial lactate, patients with a high APACHEⅡ score, high C-reactive protein levels, and chronic heart failure had a poorer prognosis.
Introduction
Sepsis was defined as suspected infection that satisfied diagnostic criteria of the systemic inflammatory response syndrome (SIRS) for the last two decades.
1,2 However, sepsis is now understood as a comprehensive host response to infecting pathogens. 3 Therefore, the definitions of sepsis and septic shock need revision.
To compensate for the fact that inflammation has various courses, while SIRS criteria does not adequately reflect the infection-induced inflammation, new definitions of sepsis and septic shock were announced through Singer et al. in February 2016. 4 Sepsis is defined as lifethreatening organ dysfunction caused by a "dysregulated host response" to infection. A Sepsis-related Organ Failure Assessment (SOFA) score !2 was selected for organ dysfunction. 4, 5 Septic shock is a subset of sepsis with underlying "circulatory and cellular metabolic abnormalities" that increase mortality. As index for diagnosis septic shock, 'need for vasopressor therapy' and 'hyperlactatemia' (lactate >2 mmol/L despite adequate fluid resuscitation) were selected by the Delphi process. 6 Lactate has been used as a prognostic marker of sepsis and septic shock. Upon contracting sepsis, patients experience hyperlactatemia caused by lactate overproduction as a consequence of tissue hypoperfusion and sepsis itself, as well as diminished lactate clearance due to hepatic dysfunction and renal dysfunction. 7 In Shankar-Hari et al., the adjusted odds ratio (OR) for hospital mortality increased linearly with increasing lactate levels. Lactate level >2 mmol/L was chosen as the cutoff value for diagnosis of septic shock. 6 However, there are many institutions that do not initially measure lactate level. 8 There are patients who with signs of septic shock with hypolactatemia show poor outcomes.
9e11 Therefore, the appropriate cutoff value for lactate level remains controversial.
Our objective was to evaluate the prognostic significance of the cutoff value for lactate through comparison of clinical presentation and outcome between septic shock patients with high and low lactate levels.
Material and methods

Patients and study design
We included critically ill patients who visited the emergency department (ED) of Severance Hospital at Yonsei University College of Medicine, a 2000-bed, tertiary referral hospital in South Korea from November 2007 to March 2016. This retrospective cohort study targeted patients enrolled in a critical pathway (CP) named Early Goal-Directed Therapy, a 6-h bundle established for managing patients with septic shock as quickly and effectively as possible. Protocol of CP was revised to reflect the guidelines of Surviving Sepsis Campaign. The protocol was approved by the institutional review board of Yonsei University Health System Clinical Trial Center. All patients visiting the ED were screened. Patients who satisfied two or more SIRS criteria and showed signs of infection were evaluated for eligibility in CP. Initiation of CP was triggered by one of the following two conditions: a) initial systolic blood pressure <90 mmHg despite adequate fluid resuscitation, or b) initial arterial lactate level !4 mmol/L. These standards followed the Surviving Sepsis Campaign guideline designed by Dellinger et al. 12 Exclusion criteria included: a) age under 18 years, b) any contraindication to central venous catheterization, c) pregnancy, d) acute cerebrovascular accident, e) acute coronary syndrome, f) active gastrointestinal bleeding, g) trauma, h) drug overdose, i) the need for immediate surgery, j) lack of informed consent, k) transfer to another institution, and l) do-not-resuscitation order. A total of 1043 patients were enrolled in this study.
The resuscitation team consisted of specialists in emergency medicine, division of infectious disease, pulmonology, and anesthesiology. Vital signs, such as blood pressure, heart rate, respiration rate, and body temperature, were checked and recorded when patients visited the ED. In septic patients, fluid resuscitation was initiated via insertion of a central venous catheter into the internal jugular vein or subclavian vein. Per protocol, crystalloids were used as resuscitative fluids and norepinephrine was used for a vasopressor. Central venous pressure (CVP), mean arterial pressure (MAP), and central venous oxygen saturation (ScvO 2 ) were checked every hour for 6 h. The success or failure of CP was analyzed using this data.
Data collection
Baseline characteristics such as age, sex, height, weight, and preexisting comorbidities, such as, hypertension, diabetes mellitus, chronic kidney disease, chronic heart failure (CHF), coronary disease, dementia, lung disease, autoimmune or connective tissue disease, liver disease, malignancy, human immunodeficiency virus infection, and history of organ transplantation were extracted. Treatment modalities and interventions in the process of treatment such as transfusion, vasopressor therapy, ventilator care, and hemodialysis were also noted.
Laboratory tests were performed according to protocol. Initially, complete blood count, C-reactive protein (CRP), blood urea nitrogen, creatinine (Cr), estimated glomerular filtration rate (eGFR), total bilirubin, albumin, lactate, prothrombin time (International Normalized Ratio), Ddimer, antithrombin Ⅲ, fibrinogen, fibrin degradation product, arterial blood gas analysis, and bacterial cultures were obtained from blood, sputum, and urine samples. Severity of disease and degree of organ failure were evaluated using the Acute Physiology and Chronic Health Evaluation (APACHEⅡ) and SOFA scores. Follow-ups continued until patients' death during hospitalization period or their first visit to outpatient clinic after patients being discharged. Occurrence of organ failure in this study was determined by reviewing the patients' medical records as well as results of laboratory tests and special examinations, such as echocardiography, within 28 days after hospitalization. Mortalities were classified as 7-day mortality, 28-day mortality, and mortality after 28 days.
Definition and resuscitation goals
The high lactate group was defined as the group of patients with arterial lactate >2 mmol/L and the low lactate group was defined as a patient group with arterial lactate 2 mmol/L or less. Thrombocytopenia was defined as the platelet count below 150 Â 10 3 cells/mm 3 . Renal failure was defined as serum Cr equal to or above 2.0 mg/dL, or urine output below 500 ml/day. 13 Acute respiratory distress syndrome was defined as the ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen below 300 mmHg and bilateral opacities not fully explained by pleural effusion, lung collapse, and nodules on chest imaging.
14 Hepatic failure was defined as serum total bilirubin equal to or above 2.0 mg/dL. 15 Newly developed heart failure (HF) was defined as left ventricular ejection fraction below 50% on echocardiography. 16 Disseminated intravascular coagulation (DIC) was diagnosed based on a score !5 according to guidelines of the International Society on Thrombosis and Hemostasis when thrombocytopenia, elevated D-dimer level, prolonged prothrombin time, and decreased fibrinogen level were combined. 17 Patients were treated according to a CP protocol for at least 6 h, after which monitoring of ScvO 2 was discontinued if the initial resuscitation goal was achieved (resuscitation criteria: CVP of 11e15 cmH 2 O, MAP of 65e90 mmHg, and ScvO 2 greater than 70% in the initial 6 h).
Statistical analysis
Continuous variables are expressed as mean AE standard deviation or median (interquartile range). Categorical variables were compared using c 2 analysis, and continuous variables with normal distributions were compared using the Student's t test. The ManneWhitney U test was used to compare continuous variables with a skewed distribution. Variables with a p value < 0.05 on bivariate analysis were included in the logistic regression model for multivariate analysis of 28-day mortality in the low lactate group.
Adjusted ORs were calculated using a logistic regression model. KaplaneMeier curves were used to compare 7-day mortality and 28-day mortality between high and low lactate groups. Single linear univariate correlation (Pearson's correlation coefficients) and simple linear regression analyses were performed to evaluate the relationship between SOFA score and serum lactate level. The optimal cutoff value for SOFA score was estimated to maximize the sum of the sensitivity and specificity derived from receiving operating characteristic curves and area under the curve (Youden index) using SOFA scores for 1022 patients. The estimated cutoff value for SOFA score in this study was 7.5 (AUC 0.713, p < 0.001). All statistical analyses were performed using the Statistical Package for the Social Sciences 18.0 software (SPSS Inc., Chicago, IL, USA). p values less than 0.05 were considered statistically significant.
Results
During the study period, we enrolled 1043 patients. We excluded 21 patients due to missing data. The high lactate group included 653 (63.9%) patients ( Fig. 1 ). Mean age of participants was 65.7 AE 14.4 years, and total mortality rate was 16.0% (164/1022). Proportion of patients who received vasopressor was 95.8% (979/1022). Table 1 shows the baseline characteristics and laboratory data of patients with high and low lactate levels. The mean age of patients in the high lactate group was higher than the low lactate group (66.9 AE 13.4 vs. 63.6 AE 15.8 years, p Z 0.010). Male sex had a significant impact on the differences between the two groups (56.0 vs. 42.5%, p < 0.001). In addition, the incidence of diabetes mellitus (36. 3.3 AE 0.7 g/dL, p < 0.001) were lower in the high lactate group than in the low lactate group.
Regarding the severity of illness at the time of admission to the ED and pre-CP, the SOFA score (9.08 AE 3.03 vs. 6.97 AE 2.32, p < 0.001) and APACHEⅡ score (18.56 AE 7.15 vs. 14.02 AE 5.97, p < 0.001) were higher in the high lactate group than in the low lactate group (Table 1) . Table 2 shows the results of resuscitation, incidence of organ failure, and mortality in the two groups. The MAP, 6 h after initiation of CP was higher in the low lactate group than in the high lactate group (81.3 AE 14.1 vs. 84.4 AE 14.6 mmHg, p Z 0.028). Six-hour CVP and ScvO 2 were not significantly different between the two groups. The high lactate group had a significantly high percentage of CP goal achievement (50.8 vs. 43.9%, p Z 0.037). Organ failure was significantly more frequent in the high lactate group than in the low lactate group. Seven-day mortality (10.3 vs. 1.6%, p < 0.001) and 28-day mortality (15.6 vs. 4.9%, p < 0.001) were significantly higher for the high lactate group than the low lactate group (Fig. 2a) .
On multivariate analysis, SOFA score of 7.5 was used as the cutoff between groups. Independent predictive factors for high levels of serum lactate in the patients with septic Arterial lactate in patients with septic shock 3 + MODEL Figure 1 . Flowchart of patient selection and clinical outcome. shock were thrombocytopenia and low eGFR were independent (Table 3 ). The SOFA score was a significant variable for predicting arterial lactate, and it showed a marked positive correlation with serum lactate in simple correlation analysis (r Z 0.394, p < 0.001) and linear regression (R 2 Z 0.155, p < 0.001; Fig. 2b ). Subgroup analysis of predictive factors for 28-day mortality in the low lactate group was performed. Nine factors were significantly associated with 28-day mortality in univariate analysis: low MAP (p Z 0.009), low initial ScvO 2 (p Z 0.037), low eGFR (p Z 0.028), low serum albumin (p Z 0.013), high CRP (p Z 0.012), high arterial lactate (p Z 0.037), high SOFA score (p < 0.001), high APACHEⅡ score (p < 0.001), and CHF (p Z 0.005). On multivariate analysis, high APACHEⅡ score (OR, 1.141; 95% CI, 1.047e1.243, p Z 0.003), high CRP (OR, 1.006; 95% CI, 1.000e1.011, p Z 0.034) and CHF (OR, 10.244; 95% CI, 2.763e37.980, p Z 0.001) were significant independent predictive factors for 28-day mortality in patients with low lactate levels ( Table 4) .
Discussion
Sepsis is a clinical syndrome of pathophysiologic and biochemical abnormalities induced by infection. The increasing incidence and high mortality rate associated with sepsis is a major public health concern worldwide. 18 The new definition for sepsis emphasizes organ dysfunction and suggests that lactate is an important marker of tissue damage even without hypotension. 4 As an index for monitoring treatment and predicting prognosis, several variables were proposed such as MAP, lactate level, ScvO 2 , and CRP. Serum lactate levels and ScvO 2 were found to be good prognostic factors in several studies. 19, 20 Mikkelsen et al. reported that initial lactate was independently associated with mortality in patients with severe sepsis. 21 Thus, lactate is an important factor in predicting the severity and outcome of septic shock patients, but controversy remains regarding the optimal cutoff value. The universally accepted lactate level representing tissue hypoxia is 4 mmol/L and is often applied when initiating resuscitation in patients with septic shock. 12 However, Bakker and colleagues reported lactate >2 mmol/L to be an independent predictor of mortality in septic shock. 22 In 2015, Casserly et al. reported that patients with lactate >2 mmol/L had significantly higher mortality (42.3% [95% CI, 41.2e43.3]) in risk-adjusted comparisons with other subgroups. 6, 23 Patients in the high lactate group had more severe clinical characteristics and poorer outcomes than those in the low lactate group. Patients in the high lactate group also had higher SOFA score and APACHEⅡ score, and their organ failure was more frequent than those in the low lactate group. In addition, 7-day and 28-day mortality rates were higher in the high lactate group than in the low lactate group. A number of recent studies have shown that high lactate levels are associated with poor clinical outcomes. 21, 24 However, a secondary analysis study comparing the prognosis of patients who met the new definition of septic shock to patients who do not meet the new diagnostic criteria, but met the previous diagnostic criteria, was recently published. In this study, low lactate level was the main reason why patients did not meet the new diagnostic criteria. Although patients with high lactate level fulfilled the new diagnostic criteria and had significantly high mortality, patients with lower lactate level also had a mortality rate of 14.4%. This mortality rate was significantly higher than the rates of severe illness, such as stroke and heart diseases. 25 Additionally, several studies were performed on the high mortality rate of patients with hypolactatemia. Nichol and colleagues found that hospital mortality was significantly increased when patients had lactate concentrations >0.75 mmol/L and surviving patients had a median blood lactate concentration of 1.2 mmol/L, while non-survivors had a median lactate concentration of 1.3 mmol/L (p < 0.001). 10 Wacharasint et al. reported an increase in mortality with lactate levels >1.4 mmol/L. 11 Therefore, it is necessary to use other variables to substitute for lactate and predict the prognosis of septic shock.
Analysis of the low lactate group revealed high APACHEⅡ score, high CRP, and CHF to be independent prognostic factors for 28-day mortality. Many investigators have demonstrated that the APACHEⅡ score is a prognostic factor influencing mortality in septic shock patients.
11,26 APACHEⅡ score is a significant prognostic factor for mortality because it is result of the calculation includes the main physiologic factors of critically ill patients. 27 CRP is a traditional and frequently used marker of sepsis and its management. Yentis et al. reported that daily estimation of CRP is very useful in monitoring the success of failure of therapy. 28 The relationship between CHF and the outcomes of septic shock remains unclear; however, decreased heart function negatively affects the outcome of septic shock. Patients in septic shock require more oxygen transport. Therefore, decreased heart function can lead to insufficiency in meeting increased oxygen demands despite decreased systemic vascular resistance resulting from septic shock. 29 The prognostic value of a positive response to dobutamine challenge in septic shock has been demonstrated in several studies. 30, 31 In another study, diastolic dysfunction was a strong independent predictor of mortality of septic shock after adjusting for other independent predictors such as age, diabetes mellitus, hypertension, APACHEⅡ score, and concurrent coronary heart disease. 32 Since lactate cannot be measured in some medical environments, especially outside of critical care settings, and as there were many cases that did not check a lactate at the time of suspected infection, even if measurement thereof was possible, we analyzed variables predicting lactate to evaluate the severity of septic shock in patients in these situations. 6, 8 Participants were divided into high and low SOFA score groups based on a cutoff value 7.5. As a result, thrombocytopenia, low eGFR, and high SOFA score group were significant risk factors based on our evaluation. Thiery-Antier et al. reported thrombocytopenia within the first 24 h of septic shock onset as a prognostic marker of 28-day mortality in intensive care unit patients. In multivariate Cox regression, a platelet count 100.0 Â 10 3 cells/mm 3 was independently associated with significantly increased 28-day mortality. Mortality increased with the severity of thrombocytopenia. 33 In our analysis, incidence of thrombocytopenia was significantly high in the high lactate group and it is a one of the significant risk factor of hyperlactatemia, but not a prognostic marker of 28-day mortality in the subgroup analysis of the low lactate group. Reflecting the pathogenesis of lactic acidosis, decreased renal function can contribute the hyperlactatemia. The kidneys contribute to lactate clearance via excretion, gluconeogenesis, and oxidation, even though they may not be a major component in lactate clearance. 34 SOFA score is of diagnostic value according to the new sepsis definition, and correlates with lactate. 4, 19 In our analysis, SOFA score showed a positive correlation with lactate, and was similar to former studies. SOFA score may play an important role in institutions that cannot measure lactate for management of septic shock. A SOFA score of 8 can be a reference point upon consideration of our analysis.
In this study, 28-day mortality was relatively lower than the mortality rates reported in other recent studies. 20, 26 In this study, 28-day mortality was 11.7% in all patients. However, total mortality rate in this study was 16.0%. After dividing total mortality by range of lactate, we found that total mortality was 25.6% (103/403) in the patient group with lactate >4 mmol/L, which was significantly higher than mortality of the patient group with lactate <1 mmol/L (5.8%, 8/138, p < 0.001). Additionally, the relatively high number of patients with urinary tract infection who were known to have a good prognosis could be a reason (n Z 294, 28.8%). In other words, these results indicate that lactate is a reliable prognostic marker in septic shock patients.
This study had several limitations. First, the clinical and biological data used in this study were collected from a single center. Second, nosocomial infections were excluded due to the collection of data from ED admissions. For the same reason, there is a possibility for selection bias. Since the initiation of CP was mainly dependent on the decision of physicians at the ED, their subjective judgment may have interfered with CP enrollment. Third, patients who needed emergency surgery with a high likelihood of septic shock were excluded from the study. Patients who needed emergency surgery were excluded in CP protocol design since the initial 6-h management bundle was difficult to apply in the same environment as other patients. However, it is not necessary to maintain the existing 6-h bundle when managing patients with septic shock according to the recently revised SSC guideline. 35 Therefore, it may be possible to enroll patients who require emergency surgery in CP in future protocol revision and research design. Finally, since this was a long-term period study, changes in medical devices, techniques, and antibiotics over time were not entirely reflected. However, this study has been carefully conducted and includes a significant number of participants while considering strict definition of septic shock. In addition, we found that the predictive power for key variables was sufficiently high in the final multivariate logistic regression model.
Our study demonstrates that arterial lactate level is a very reliable diagnostic and prognostic predictor of septic shock. SOFA score correlated well with arterial lactate. However, there were not inconsiderable cases of mortality in patients without hyperlactatemia. In the low lactate group, high APACHEⅡ score, high CRP, and CHF affected the mortality rate independently. Re-examination of arterial lactate should be considered when treating patients with suspected septic shock and low arterial lactate, if the patient has high APACHEⅡ score, high CRP, and CHF. Further studies are needed that will identify other predictive factors for high-risk cases of septic shock without hyperlactatemia.
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